Mazdutide activates both GLP-1 and glucagon receptors, providing complementary metabolic benefits beyond GLP-1 alone.
Dual Mechanism
- GLP-1: Appetite suppression, insulin secretion
- Glucagon: Increased energy expenditure, fat oxidation
Research Benefits
- Enhanced weight loss
- Improved glycemic control
- Increased metabolic rate
- Liver fat reduction
Dosing
Titrated weekly dosing similar to other GLP-1s.
Research-grade peptides contain only the active ingredient and are NOT equivalent to FDA-approved pharmaceuticals.